Autres langues McKesson Corporation

Actions

MCK

US58155Q1031

Produits pharmaceutiques

Temps réel estimé Cboe BZX 16:57:38 28/09/2026			Varia. 5j.	Varia. 1 janv.
859,72 ^USD	-0,80%		-2,61%	+5,25%

14/09	McKesson reste confronté à des vents contraires à moyen terme liés à la baisse de la couverture des GLP-1 par les employeurs, selon RBC	MT
14/09	Transcript : McKesson Corporation Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 07:45 AM

Autres langues

23/09	McKesson Corporation Announces Second Quarter Fiscal 2027 Earnings Release Date
14/09	McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says
31/08	Afternoon Meeting: La Fed, el petróleo y un septiembre complicado
31/08	Die Fed, Öl und ein schwieriger September
31/08	The Fed, Oil And a Difficult September
31/08	Morning Meeting: Warsh geht in die Offensive
28/08	McKesson Reports Cybersecurity Incident
25/08	Equities Rise Despite US-Canada Trade Tensions
25/08	Equities Rise Intraday, Oil Falls as Markets Monitor Trade Developments
25/08	McKesson to Buy Precision Medicine in $2.25 Billion Deal
25/08	McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group, LLC for approximately $2.3 billion.
25/08	McKesson to Acquire Precision Medicine Group for About $2.25 Billion
25/08	McKesson to Buy Precision Medicine Group for Roughly $2.25 Billion
25/08	McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets
25/08	McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
20/08	Government Drops Statute Of Limitations Defense In McKesson Cost-sharing Challenge
19/08	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says
11/08	Mckesson Insider Sold Shares Worth $268,590, According to a Recent SEC Filing
05/08	Tranche Update on McKesson Corporation's Equity Buyback Plan announced on May 24, 2018.
05/08	McKesson raises annual profit forecast on strong growth in specialty drug business
05/08	McKesson: Fiscal Q1 Earnings Snapshot
05/08	McKesson Fiscal Q1 Adjusted Earnings, Revenue Rise; Lifts Fiscal 2027 Guidance
05/08	(MCK) McKesson Now Expects Fiscal 2027 Adjusted EPS Range $44.20-$45.00, vs. FactSet Est of $44.26
05/08	Earnings Flash (MCK) McKesson Posts Fiscal Q1 Adjusted EPS $9.93, vs. FactSet Est of $9.56
05/08	Earnings Flash (MCK) McKesson Posts Fiscal Q1 Revenue $105.38B, vs. FactSet Est of $103.88B